BeOne Medicines
ONC
#661
Rank
A$53.45 B
Marketcap
A$483.07
Share price
0.78%
Change (1 day)
49.79%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Sustainability Reports

Thumbnail BeOne Medicines Sustainability Report 2023

Sustainability Report 2023

Language: English

View Sustainability Report
Thumbnail BeOne Medicines Sustainability Report 2020

Sustainability Report 2020

Language: English

View Sustainability Report